Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant.

Bhattacharyya, Roby P; Hanage, William P

Bhattacharyya, Roby P; Hanage, William P.

Bhattacharyya RP; From the Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital (R.P.B.), and the Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health (W.P.H.) - both in Boston.
Hanage WP; From the Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital (R.P.B.), and the Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health (W.P.H.) - both in Boston.

N Engl J Med ; 386(7): e14, 2022 Feb 17.

Article in English | MEDLINE | ID: covidwho-1671717

Subject(s)

COVID-19/virology; Patient Acuity; SARS-CoV-2/pathogenicity; COVID-19/epidemiology; COVID-19/mortality; COVID-19/transmission; Humans; South Africa/epidemiology; Virulence

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Acuity / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: N Engl J Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google